(HealthDay)—Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are highly effective for reducing hepatic steatosis in patients with severe obesity and type 2 diabetes, with almost complete clearance of liver fat ...
Nov 30, 2021
0
6
Researchers at the University of Toronto and its partner hospitals have discovered a way to generate functional cells from stem cells that could open new treatment avenues for people with cystic fibrosis who have liver disease.
Nov 22, 2021
0
76
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, found a link between larger waistlines and the progression of non-alcoholic fatty liver ...
Sep 30, 2021
0
4
Findings of a national study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, identify potential biomarkers that might eventually be used to diagnose progressive stages of liver disease.
Sep 20, 2021
0
6
Non-alcoholic fatty liver disease is the most common liver disorder worldwide and is present in approximately 25 percent of the world's population. Over 90 percent of obese, 60 percent of diabetic, and up to 20 percent of ...
Jul 13, 2021
0
8
Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine ...
Jul 12, 2021
0
10
Skoltech biologists and their colleagues from Koltzov Institute of Developmental Biology, Russia, and the Chemistry Department of Taras Shevchenko University in Ukraine have discovered fairly unlikely drug candidates for ...
Jul 08, 2021
0
1
Research by the University of Valencia, CIBERehd and FISABIO offers an exhaustive analysis of the different published studies on autophagy, a cellular process involved in liver fibrosis. The work addresses the different aspects ...
Jul 01, 2021
0
2
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and can progress to liver cirrhosis, liver failure or cancer. Currently, nonalcoholic steatohepatitis (NASH) diagnosis requires an invasive ...
Jun 17, 2021
0
3
Scientists from Russia and Italy studied a new axis of the pathway that prevents the development of liver fibrosis. The role of GILZ protein in curbing the disease progression was shown in a study using mice models and confirmed ...
May 04, 2021
0
10
